SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-418841
Filing Date
2013-10-30
Accepted
2013-10-30 17:17:11
Documents
14
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d593257d10q.htm 10-Q 500742
2 EX-10.1 d593257dex101.htm EX-10.1 29545
3 EX-10.2 d593257dex102.htm EX-10.2 14928
4 EX-10.3 d593257dex103.htm EX-10.3 32318
5 EX-10.4 d593257dex104.htm EX-10.4 8311
6 EX-31.1 d593257dex311.htm EX-31.1 7521
7 EX-31.2 d593257dex312.htm EX-31.2 7918
8 EX-32 d593257dex32.htm EX-32 7448
  Complete submission text file 0001193125-13-418841.txt   2856088

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ctic-20130930.xml EX-101.INS 255958
10 XBRL TAXONOMY EXTENSION SCHEMA ctic-20130930.xsd EX-101.SCH 29257
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctic-20130930_cal.xml EX-101.CAL 48434
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctic-20130930_def.xml EX-101.DEF 168961
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctic-20130930_lab.xml EX-101.LAB 247331
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctic-20130930_pre.xml EX-101.PRE 197593
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12465 | Film No.: 131180128
SIC: 2834 Pharmaceutical Preparations